Breast cancer
INACTIVE --- Systemic therapy for early stage triple-negative breast cancer

Rachel (56 years old)

Rachel, 56 years old, works in a patent office and checks if the submitted applications fulfil the requirements for patentability. To clear her mind after a working day, she attends an intense 30-minute spin class every evening. Recently she felt a lump in her right breast.

Assessment summary

  • Postmenopausal
  • No family history of breast or ovarian cancer
  • No relevant medical history, ECOG PS: 0
  • Tumour size: cT2 (45 mm), LN status: cN2
  • Tumour biology:
    • Ductal invasive carcinoma of NST
    • ER 0%, PgR 0%, HER2 0
    • Ki67 70%
    • G3
  • CT scan thorax/abdomen and bone scan: cM0

Which neoadjuvant treatment option would you choose for this patient?